STOCK TITAN

Mannatech Financials

MTEX
Trailing 12 months to June 30, 2026
Revenue $107.4M -5.0% YoY
Net Income -$7.4M -89.7% YoY
EPS (Diluted) -$3.91 -91.7% YoY
Free Cash Flow $1.6M +152.7% YoY
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD FYE December

Mannatech (MTEX) reported $107.4M in revenue over the twelve months to Jun 30, 2026, down 5.0% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI MTEX FY2025

Revenue erosion is being countered by SG&A cuts, but cash burn and a negative-equity shift now dominate.

A near-breakeven operating result of -$426K became a -$15.2M net loss because taxes, not the core cost structure, dominated reported earnings. That matters because SG&A restraint kept the business close to operating breakeven even as sales fell, yet free cash flow still dropped to -$4.3M, so the operating fix has not restored cash generation.

The working-capital pattern is inventory-heavy rather than receivable-heavy: accounts receivable were just $1K in FY2025, while inventory was $10.1M, so cash is tied up in stock on hand more than in customer IOUs. That is a different cash drag from slow collections.

Short-term liquidity remains narrow but positive, with a current ratio of 1.1x. The deeper change is solvency: equity swung from $8.6M to -$5.2M in one year, so the company now relies on liabilities to fund more than all of its asset base.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Cash Runway Dilution R&DIntensity Revenue Progress BurnTrend BalanceSheet 37 / 100
Financial Health Score 37/100
Scored as: Emerging companies peer group

Scored against emerging companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Mannatech's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Cash Runway
50
Dilution
68
R&D Intensity
7
Revenue Progress
35
Burn Trend
32
Balance Sheet
28
Altman Z-Score Safe
3.21

Mannatech scores 3.21, well above the 2.99 safe threshold. This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial
2/8

Mannatech passes 2 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 1 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), 1 of 2 efficiency signals pass.

Earnings Quality No Cash Backing
N/A

Mannatech reported a net loss of $15.2M while operations used $3.0M of cash. With neither figure positive, the ratio between the two carries no quality signal.

Interest Coverage At Risk
N/A

Mannatech reported an operating loss of $426K against $406K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$108.0M
YoY-8.3%
5Y CAGR-6.5%
10Y CAGR-5.0%

Mannatech generated $108.0M in revenue in fiscal year 2025. This represents a decrease of 8.3% from the prior year.

EBITDA
$666K
YoY-77.5%
5Y CAGR-36.6%
10Y CAGR-26.2%

Mannatech's EBITDA was $666K in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 77.5% from the prior year.

Net Income
-$15.2M
YoY-708.0%

Mannatech reported -$15.2M in net income in fiscal year 2025. This represents a decrease of 708.0% from the prior year.

EPS (Diluted)
-$8.00
YoY-706.1%

Mannatech earned -$8.00 per diluted share (EPS) in fiscal year 2025. This represents a decrease of 706.1% from the prior year.

Cash & Balance Sheet

Free Cash Flow
-$4.3M
YoY-319.8%

Mannatech recorded an outflow of $4.3M in free cash flow in fiscal year 2025, representing a cash shortfall after capex. This represents a decrease of 319.8% from the prior year.

Cash & Debt
$6.2M
YoY-45.7%
5Y CAGR-22.6%
10Y CAGR-15.2%

Mannatech held $6.2M in cash against $2.8M in long-term debt as of fiscal year 2025.

Shares Outstanding
2M
YoY+1.5%
5Y CAGR-1.4%
10Y CAGR-3.3%

Mannatech had 2M shares outstanding in fiscal year 2025. This represents an increase of 1.5% from the prior year.

Dividends Per Share

Not reported for fiscal year 2025.

Margins & Returns

Gross Margin
74.9%
YoY-2.7pp
5Y CAGR-1.6pp
10Y CAGR-6.1pp

Mannatech's gross margin was 74.9% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is down 2.7 percentage points from the prior year.

Operating Margin
-0.4%
YoY-1.6pp
5Y CAGR-3.4pp
10Y CAGR-7.1pp

Mannatech's operating margin was -0.4% in fiscal year 2025, reflecting core business profitability. This is down 1.6 percentage points from the prior year.

Net Margin
-14.1%
YoY-16.2pp
5Y CAGR-18.2pp
10Y CAGR-17.3pp

Mannatech's net profit margin was -14.1% in fiscal year 2025, showing the share of revenue converted to profit. This is down 16.2 percentage points from the prior year.

Return on Equity

Not reported for fiscal year 2025.

Capital Allocation

R&D Spending
$800K
YoY+14.3%
5Y CAGR0.0%
10Y CAGR-7.3%

Mannatech invested $800K in research and development in fiscal year 2025. This represents an increase of 14.3% from the prior year.

Capital Expenditures
$1.4M
YoY+355.6%
5Y CAGR+7.4%
10Y CAGR-3.7%

Mannatech invested $1.4M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 355.6% from the prior year.

Share Buybacks

Not reported for fiscal year 2025.

MTEX Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

MTEX quarterly income statement
MetricQ2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24
Revenue$26.6M+7.0%$24.9M-6.5%$26.6M-8.7%$29.2M+13.6%$25.7M-3.3%$26.6M-8.4%$29.0M-8.6%$31.7M
Cost of Revenue$6.2M+1.8%$6.1M-8.0%$6.6M-4.4%$6.9M+1.7%$6.8M-0.7%$6.8M+21.0%$5.6M-30.4%$8.1M
Gross Profit$20.5M+8.6%$18.9M-5.9%$20.1M-10.0%$22.3M+17.8%$18.9M-4.2%$19.7M-15.5%$23.4M-1.1%$23.6M
SG&A Expenses$9.0M-3.3%$9.3M-5.2%$9.8M+7.9%$9.1M-15.8%$10.8M+7.6%$10.0M-4.0%$10.4M+6.0%$9.8M
Operating Income$998K+654.4%-$180K-14.6%-$157K-107.8%$2.0M+239.1%-$1.4M-73.2%-$833K-196.3%$865K-2.5%$887K
Interest Expense$117K+12.5%$104K-18.1%$127K+22.1%$104K+2.0%$102K+39.7%$73K-70.6%$248K+127.5%$109K
Income Tax$150K-6.8%$161K-98.6%$11.5M+1850.0%$590K+2465.2%$23K-88.8%$206K-66.4%$614K+257.8%-$389K
Net Income$1.0M+6.8%$950K+108.4%-$11.3M-686.4%$1.9M+144.6%-$4.3M-181.8%-$1.5M-167.3%$2.3M+792.7%-$328K
EPS (Diluted)$0.53+8.2%$0.49+108.2%-$5.94-688.1%$1.01+144.5%-$2.27-183.8%-$0.80-166.7%$1.20+805.9%-$0.17

Not reported in any period shown, so not listed: R&D Expenses.

MTEX Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

MTEX quarterly balance sheet
MetricQ2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24
Total Assets$27.5M-8.1%$29.9M-0.4%$30.0M-11.6%$33.9MN/A$36.7M+1.7%$36.1M-11.1%$40.6M
Current Assets$19.4M-8.4%$21.2M+3.0%$20.6M-6.8%$22.1MN/A$26.5M+1.6%$26.1M-9.0%$28.7M
Cash & Equivalents$6.0M-14.0%$7.0M+13.4%$6.2M-13.4%$7.1MN/A$9.3M-18.2%$11.4M-6.2%$12.2M
Inventory$9.6M-0.8%$9.7M-4.4%$10.1M-9.0%$11.1MN/A$11.8M+13.6%$10.4M-10.8%$11.7M
Accounts Receivable$137K+1270.0%$10K+900.0%$1K-97.4%$38KN/A$102K+436.8%$19K-13.6%$22K
Total Liabilities$32.4M-8.5%$35.4M+0.6%$35.2M+30.6%$27.0MN/A$29.1M+6.0%$27.4M-10.2%$30.6M
Current Liabilities$16.9M-13.4%$19.5M+3.9%$18.7M-3.9%$19.5MN/A$22.6M+8.0%$20.9M-9.0%$23.0M
Long-Term Debt$2.8M0.0%$2.8M0.0%$2.8M-5.2%$2.9MN/AN/AN/AN/A
Total Equity-$5.0M+10.5%-$5.6M-6.3%-$5.2M-175.2%$7.0M+16.5%$6.0M-21.4%$7.6M-11.9%$8.6M-13.9%$10.0M
Retained Earnings-$12.1M+7.8%-$13.1M+6.8%-$14.0M-413.9%-$2.7MN/A-$341K-128.7%$1.2M+210.8%-$1.1M

Not reported in any period shown, so not listed: Goodwill.

MTEX Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

MTEX quarterly cash flow statement
MetricQ2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24
Operating Cash Flow-$792K-170.3%$1.1M+489.6%-$289K-112.0%$2.4M+164.9%-$3.7M-171.8%-$1.4M-524.7%-$219K-106.7%$3.3M
Capital Expenditures$10K-92.2%$129K-25.9%$174K-68.2%$548K+285.9%$142K-71.0%$489K+361.3%-$106K-59.2%$260K
Free Cash Flow-$802K-180.4%$997K+315.3%-$463K-124.8%$1.9M+148.3%-$3.9M-107.9%-$1.9M-471.4%-$325K-110.8%$3.0M
Investing Cash Flow-$10K+92.2%-$129K+25.9%-$174K+68.2%-$548K-285.9%-$142K+71.0%-$489K-514.4%$118K+145.4%-$260K
Financing Cash Flow$228K+281.0%-$126K+47.9%-$242K-231.5%-$73K+8.8%-$80K+51.8%-$166K+81.7%-$905K-272.4%-$243K
Dividends PaidN/AN/AN/AN/AN/AN/A$0$0
Share BuybacksN/AN/AN/AN/AN/AN/A$0$0

MTEX Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples.

MTEX quarterly financial ratios
MetricQ2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24
Gross Margin76.9%+1.2pp75.7%+0.4pp75.3%-1.1pp76.4%+2.8pp73.6%-0.7pp74.3%-6.3pp80.5%+6.1pp74.5%
Operating Margin3.7%+4.5pp-0.7%-0.1pp-0.6%-7.5pp6.9%+12.5pp-5.6%-2.5pp-3.1%-6.1pp3.0%+0.2pp2.8%
Net Margin3.8%0.0pp3.8%+46.2pp-42.4%-49.0pp6.6%+23.4pp-16.8%-11.0pp-5.8%-13.6pp7.8%+8.9pp-1.0%
Return on EquityN/AN/AN/A27.7%+100.0pp-72.3%-52.1pp-20.2%-46.5pp26.4%+29.7pp-3.3%
Return on Assets3.7%+0.5pp3.2%+40.8pp-37.6%-43.3pp5.7%N/A-4.2%-10.5pp6.3%+7.1pp-0.8%
Current Ratio1.15+0.1x1.090.0x1.100.0x1.13N/A1.18-0.1x1.250.0x1.25
Debt-to-EquityN/AN/AN/A0.42N/A3.83+0.6x3.19+0.1x3.06
FCF Margin-3.0%-7.0pp4.0%+5.7pp-1.7%-8.1pp6.4%+21.4pp-15.0%-8.0pp-7.0%-5.9pp-1.1%-10.6pp9.5%

Note: Shareholder equity is negative (-$5.2M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Similar Companies

Frequently Asked Questions

What is Mannatech's annual revenue?

Mannatech (MTEX) reported $108.0M in total revenue for fiscal year 2025. This represents a -8.3% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Mannatech's revenue growing?

Mannatech (MTEX) revenue declined by 8.3% year-over-year, from $117.9M to $108.0M in fiscal year 2025.

Is Mannatech profitable?

No, Mannatech (MTEX) reported a net income of -$15.2M in fiscal year 2025, with a net profit margin of -14.1%.

Mannatech (MTEX) reported diluted earnings per share of -$8.00 for fiscal year 2025. This represents a -706.1% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Mannatech (MTEX) had EBITDA of $666K in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

As of fiscal year 2025, Mannatech (MTEX) had $6.2M in cash and equivalents against $2.8M in long-term debt.

Mannatech (MTEX) had a gross margin of 74.9% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

Mannatech (MTEX) had an operating margin of -0.4% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

Mannatech (MTEX) had a net profit margin of -14.1% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Mannatech (MTEX) recorded an outflow of $4.3M in free cash flow during fiscal year 2025. This represents a -319.8% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Mannatech (MTEX) recorded an outflow of $3.0M in operating cash flow during fiscal year 2025, representing cash used by core business activities.

Mannatech (MTEX) had $30.0M in total assets as of fiscal year 2025, including both current and long-term assets.

Mannatech (MTEX) invested $1.4M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Mannatech (MTEX) invested $800K in research and development during fiscal year 2025.

Mannatech (MTEX) had 2M shares outstanding as of fiscal year 2025.

Mannatech (MTEX) had a current ratio of 1.10 as of fiscal year 2025, which is considered adequate.

Mannatech (MTEX) had a return on assets of -50.7% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

At the end of fiscal year 2025, Mannatech (MTEX) held $6.2M in cash, cash equivalents and investments, and reported an operating cash outflow of $3.0M over that year. Dividing the one by the other, the reported balance equals about 25 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.

Mannatech (MTEX) has negative shareholder equity of -$5.2M as of fiscal year 2025, so no debt-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

Mannatech (MTEX) has an Altman Z-Score of 3.21, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

Mannatech (MTEX) has a Piotroski F-Score of 2 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Mannatech (MTEX) reported a net loss of $15.2M while operations used $3.0M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Mannatech (MTEX) reported an operating loss of $426K against $406K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

Mannatech (MTEX) scores 37 out of 100 on our Financial Health Score, indicating weak standing within its emerging companies peer group. The score is a 0-100 composite of six dimensions (Cash Runway, Dilution, R&D Intensity, Revenue Progress, Burn Trend, Balance Sheet), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top